Hikma Pharmaceutical | HIK - Créanciers Commerciaux

Prix De L'Action
1,465.00
Variation Quotidienne
-2.00 -0.14%
Mensuellement
4.46%
Annuel
-29.43%
Q2 Prévisions
1,414.37




Créanciers Commerciaux Changement Date
Almirall EUR 258.05M 58.66M 2025-12
argenx SE USD 554.27M 297.94M 2025-12
AstraZeneca USD 22.51B 2.78B 2026-03
Autolus Therapeutics Ltd USD 1.87M 1.21M 2026-03
Bayer EUR 6.59B 496M 2026-03
Fresenius EUR 1.65B 564M 2025-12
Genmab DKK 6M 2M 2025-09
GlaxoSmithKline GBP 14.34B 1.05B 2026-03
GRIFOLS EUR 841M 37.68M 2025-12
Hikma Pharmaceutical USD 715M 104M 2025-12
Lakefront Biotherapeutics EUR 95.77M 8.88M 2026-03
Lonza CHF 471M 3M 2024-12
Merck EUR 2.13B 19M 2026-03
Orion EUR 150.3M 26.8M 2026-03
Recordati EUR 306.9M 38.29M 2026-03
Roche Holding CHF 5.78B 1.27B 2025-12
Sanofi EUR 22.71B 219M 2026-03
UCB EUR 4.04B 755M 2025-12